Excell
Biotech Ltd. specializes in the provision of process development
and cGMP manufacturing services for the production of biopharmaceuticals,
used in Phase I and Phase II clinical trials, to biotechnology
and pharmaceutical customers. The services include protein production
using mammalian, microbial or insect cell culture and gene delivery
utilizing viral host systems. Excell Biotech is strategically
committed to providing contract services and manufacturing of
biotechnology products.
In
the past year Excell Biotech has seen outstanding growth, which
has driven the investment the company has made in a new, purpose
built, state-of-the-art manufacturing facility, located in Livingston,
Scotland, UK. The facility is one of the most advanced, flexible,
contract manufacturing plants in the world and will accommodate
Excell Biotech’s expected growth as the demand for outsourced
manufacture of biopharmaceuticals continues to expand worldwide.
